Chat with us, powered by LiveChat
4th New Product Planning Summit - Revere Hotel Boston Common

4th New Product Planning Summit
December 2–3, 2019
Revere Hotel Boston Common
Boston, MA

Improve early stage decision-making, optimize lifecycle management, and tailor product plans to ensure the successful commercialization of new drugs

Agenda – 4th New Product Planning Summit



Main Conference Day One

 

8:45AM – 9:00AM

Chairperson’s Opening Remarks


Tony Russell, Senior Director, Product Strategy and Commercial Planning, THERAVANCE BIOPHARMA

9:00AM – 9:45AM

Why New Product Planning Fails (More Often Than It Succeeds) and the Fix!


Paul Harney, President, North America, PRESCIENT HEALTHCARE GROUP
Debasish Talukdar, Global Head of Advisory, PRESCIENT HEALTHCARE GROUP

9:45AM – 10:30AM

Interactive Group Discussion


Tony Russell, Senior Director, Product Strategy and Commercial Planning, THERAVANCE BIOPHARMA

10:30AM – 11:00AM

Networking Break


11:00AM – 11:45AM

Keep Pace With New Paradigms in Oncology


Alexander Brown, New Product Planning Oncology, SANOFI

11:45AM – 12:30PM

Gene Therapy Is a Reality – Now How Do We Successfully Commercialize It?


Parag V. Meswani, Pharm.D., SVP, Commercial Strategy and Operations, AXOVANT SCIENCES

12:30PM – 1:30PM

Luncheon


1:30PM – 2:15PM

Early Stage Target Product Profiles (TPPs) and Opportunity Valuations


Réka Shinkle, Vice President, Commercial and Portfolio Planning, REGENXBIO

3:00PM – 3:30PM

Networking Break


3:30PM – 4:15PM

Create a Successful Therapeutic Disease Area Strategy


Katja Wachtendonk, Worldwide Director New Products, NOVARTIS PHARMACEUTICALS

4:15PM – 5:00PM

Market Maps: Driving Disproportionate Growth Through Identifying Where and How to Compete


Elaine Hughes, MBA, Executive Director, Commercial Development, CELGENE

5:00PM – 5:00PM

Day One Concludes



Main Conference Day Two

 

8:00AM – 8:45AM

Continental Breakfast


8:45AM – 9:00AM

Chairperson’s Opening Remarks


Tony Russell, Senior Director, Product Strategy and Commercial Planning, THERAVANCE BIOPHARMA

9:00AM – 9:45AM

Plan for Value and Access on Both Sides of the Pond


Arup Pramanik, M.D., M.Sc., Vice President, Market Access and Strategy, INDIVIOR

9:45AM – 10:30AM

Panel: When Do You Incorporate Market Access Considerations Into Product Commercialization?


Nayahmka McGriff-Lee, Product and Portfolio Strategy Director, Early Pipeline and Portfolio Strategy, GSK
Arup Pramanik, M.D., M.Sc., Vice President, Market Access and Strategy, INDIVIOR

10:30AM – 11:00AM

Networking Break


11:00AM – 11:45AM

Early Integrated New Product Planning Leads to Launch Success


Anne Marie Robertson, Vice President, Onivyde Marketing, North American Commercial Operations, IPSEN BIOPHARMACEUTICALS

11:45AM – 12:30PM

Aligning Internal Teams to Ensure Success in New Product Planning and Launches


Michael P. Bentivegna, Vice President, Commercial Development and Lifecycle Innovation, ZOETIS

12:30PM – 1:30PM

Luncheon


1:30PM – 2:15PM

Develop a “Glocal” Commercialization Strategy


Christine Leighland, Head, New Product Planning, BIOGEN

2:15PM – 3:00PM

New and Approved! Strategic Considerations for Effectively Launching a New Indication for a Marketed Drug


Eric Gornstein, Vice President of Commercial Strategy and Business Development, TALARIS THERAPEUTICS

3:00PM – 3:30PM

Networking Break


3:30PM – 4:15PM

Nexus of New Product Planning and Corporate/Business Development


Erin Brubaker, Vice President of Commercial Strategy and Business Development, ZAFGEN

4:15PM – 5:00PM

How and When to Kill a Program in New Product Planning


Tony Russell, Senior Director, Product Strategy and Commercial Planning, THERAVANCE BIOPHARMA

5:00PM – 5:15PM

Chairperson’s Closing Remarks


Tony Russell, Senior Director, Product Strategy and Commercial Planning, THERAVANCE BIOPHARMA

5:15PM – 5:15PM

Conference Concludes



live chat software